Inventor · disambiguated record
Annemieke Aartsma-Rus
Also filed as: AARTSMA-RUS ANNEMIEKE
12 granted patents·17 pending applications·363 citations·filing 2005–2020
93Inventor score
Files withACADEMISCH ZIEKENHUIS LEIDEN13BIOMARIN TECH BV5PROSENSA TECHNOLOGIES BV3DE KIMPE JOSEPHUS JOHANNES2VAN OMMEN GARRIT JAN BOUDEWIJN2
Top patents by PatentIndex Score
29 records- 0198US8361979B2Means and method for inducing exon-skippingACADEMISCH ZIEKENHUIS LEIDEN·Filed 2007·Granted Jan 29, 2013·142 cites·7 claims
- 0297USRE48468EMeans and methods for counteracting muscle disordersBIOMARIN TECH BV·Filed 2018·Granted Mar 16, 2021·25 cites·42 claims
- 0397US9926557B2Methods and means for efficient skipping of exon 45 in Duchenne muscular dystrophy pre-mRNADE KIMPE JOSEPHUS JOHANNES·Filed 2011·Granted Mar 27, 2018·50 cites·11 claims
- 0497US9243245B2Means and methods for counteracting muscle disordersDE KIMPE JOSEPHUS JOHANNES·Filed 2010·Granted Jan 26, 2016·76 cites·22 claims
- 0594US9139828B2Method for efficient exon (44) skipping in duchenne muscular dystrophy and associated meansPLATENBURG GERARD JOHANNES·Filed 2010·Granted Sep 22, 2015·41 cites·15 claims
- 0687US10364432B2Antisense oligonucleotide directed removal of proteolytic cleavage sites from proteinsACADEMISCH ZIEKENHUIS LEIDEN·Filed 2017·Granted Jul 30, 2019·7 cites·4 claims
- 0784US9896687B2Modulation of exon recognition in pre-mRNA by interfering with the secondary RNA structureVAN OMMEN GARRIT JAN BOUDEWIJN·Filed 2005·Granted Feb 20, 2018·4 cites·1 claims
- 0883US8802645B2Molecule for treating an inflammatory disorderVAN OMMEN GARRIT-JAN BOUDEWIJN·Filed 2012·Granted Aug 12, 2014·13 cites·23 claims
- 0978US10113165B2Modulation of exon recognition in pre-mRNA by interfering with the secondary RNA structureACADEMISCH ZIEKENHUIS LEIDEN·Filed 2014·Granted Oct 30, 2018·1 cites·13 claims
- 1074US10246707B2Method for efficient exon (44) skipping in duchenne muscular dystrophy and associated meansBIOMARIN TECH BV·Filed 2015·Granted Apr 2, 2019·1 cites·12 claims
- 1172US9611471B2Antisense oligonucleotide directed removal of proteolytic cleavage sites from proteinsVAN ROON-MOM WILHELMINA M C·Filed 2011·Granted Apr 4, 2017·3 cites·6 claims
- 1270US2020332298A1Antisense oligonucleotide directed removal of proteolytic cleavage sites from proteinsACADEMISCH ZIEKENHUIS LEIDEN·Filed 2019·Application pending·0 cites
- 1370US2021207138A1Method for efficient exon (44) skipping in duchenne muscular dystrophy and associated meansBIOMARIN TECH BV·Filed 2020·Application pending·0 cites
- 1468US2014221458A1METHODS AND MEANS FOR EFFICIENT SKIPPING OF EXON 45 IN DUCHENNE MUSCULAR DYSTROPHY PRE-mRNAPROSENSA TECHNOLOGIES BV·Filed 2014·Application pending·0 cites
- 1568US2014357855A1Modulation of exon recognition in pre-mrna by interfering with the secondary rna structureACADEMISCH ZIEKENHUIS LEIDEN·Filed 2014·Application pending·0 cites
- 1668US2020224203A1Antisense oligonucleotide directed removal of proteolytic cleavage sites, the hchwa-d mutation, and trinucleotide repeat expansionsACADEMISCH ZIEKENHUIS LEIDEN·Filed 2020·Application pending·0 cites
- 1768US2014113955A1METHODS AND MEANS FOR EFFICIENT SKIPPING OF EXON 45 IN DUCHENNE MUSCULAR DYSTROPHY PRE-mRNAPROSENSA TECHNOLOGIES BV·Filed 2013·Application pending·0 cites
- 1868US2014128592A1METHODS AND MEANS FOR EFFICIENT SKIPPING OF EXON 45 IN DUCHENNE MUSCULAR DYSTROPHY PRE-mRNAPROSENSA TECHNOLOGIES BV·Filed 2013·Application pending·0 cites
- 1968US2014357698A1Modulation of exon recognition in pre-mrna by interfering with the secondary rna structureACADEMISCH ZIEKENHUIS LEIDEN·Filed 2014·Application pending·0 cites
- 2065US2016194636A1Modulation of exon recognition in pre-mrna by interfering with the secondary rna structureACADEMISCH ZIEKENHUIS LEIDEN·Filed 2016·Application pending·0 cites
- 2165US2016168570A1Modulation of exon recognition in pre-mrna by interfering with the secondary rna structureACADEMISCH ZIEKENHUIS LEIDEN·Filed 2016·Application pending·0 cites
- 2265US2016251658A1Modulation of exon recognition in pre-mrna by interfering with the secondary rna structureACADEMISCH ZIEKENHUIS LEIDEN·Filed 2016·Application pending·0 cites
- 2364US2016304864A1Means and methods for counteracting muscle disordersBIOMARIN TECH BV·Filed 2016·Application pending·0 cites
- 2462US2015218559A1Modulation of exon recognition in pre-mrna by interfering with the secondary rna structureACADEMISCH ZIEKENHUIS LEIDEN·Filed 2015·Application pending·0 cites
- 2562US2019292541A1Method for efficient exon (44) skipping in duchenne muscular dystrophy and associated meansBIOMARIN TECH BV·Filed 2019·Application pending·0 cites
- 2661US10590421B2Antisense oligonucleotide directed removal of proteolytic cleavage sites, the HCHWA-D mutation, and trinucleotide repeat expansionsACADEMISCH ZIEKENHUIS LEIDEN·Filed 2017·Granted Mar 17, 2020·0 cites·7 claims
- 2760US2014039037A1Antisense oligonucleotide directed removal of proteolytic cleavage sites, the hchwa-d mutation, and trinucleotide repeat expansionsACADEMISCH ZIEKENHUIS LEIDEN·Filed 2013·Application pending·0 cites
- 2851US2012270930A1Methods and compositions for dysferlin exon-skippingVAN DER MAAREL SILVERE MARIA·Filed 2009·Application pending·0 cites
- 2951US2009312532A1Modulation of exon recognition in pre-mrna by interfering with the binding of sr proteins and by interfering with secodary rna structureVAN DEUTEKOM JUDITH CHRISTINA·Filed 2006·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Annemieke Aartsma-Rus files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →